Corporate Profile

Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
Recent NewsMore »
Teleflex to Promote the Rise of the Vascular Access Specialist and Demonstrate Arrow® Brand Products at the Association for Vascular Access® (AVA) 2016 Congress in Orlando, FL
WAYNE, Pa.--(BUSINESS WIRE)--Sep. 16, 2016-- Teleflex Incorporated (NYSE: TFX), a leading provider of medical technologies for critical care and surgery, will focus on the rise of the vascular access specialist with its vascular access technologies and new educational platform at the 30th Annual Scientific Meeting of the Association for Vascular Access (AVA), in Orlando, Florida, to be held September 16-19, 2016. The rise of the vascular a... 
Teleflex to Present Innovative Interventional Access Technologies at the Annual Meeting and Postgraduate Course of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), to be Held in Barcelona, Spain on September 10-13, 2016
WAYNE, Pa.--(BUSINESS WIRE)--Sep. 9, 2016-- Teleflex Incorporated (NYSE: TFX) a leading global provider of medical devices for critical care, urology and surgery will showcase two of its advanced Arrow® Interventional Access Products at the Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) in Barcelona. During the event, Teleflex will highlight both the Arrow® OnControl® Powered Bone Access Sys... 
Teleflex to Present at the 2016 Morgan Stanley Global Healthcare Conference
WAYNE, Pa.--(BUSINESS WIRE)--Sep. 8, 2016-- Benson Smith, Chairman and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2016 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City, Wednesday, September 14, 2016 at 11:40 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website ... 
The Difficult Airway Society (DAS) Launches Inaugural Project Grant to Support Formal Evaluation of Second-Generation Supraglottic Airway Devices (SADs) in Accordance with ADEPT (Airway Device Evaluation Project Team) Guidance
WAYNE, Pa.--(BUSINESS WIRE)--Aug. 18, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has today announced its support of the Difficult Airway Society with the launch of the first research grant directed to ADEPT Guidance. The research grant, which will be funded by Teleflex and administered by the Difficult Airway Society, will support the evaluation of second-generation SADs. ... 
Upcoming EventsMore »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet